1. Lee, Hyunji, Chin, Hyunjung, Kim, Hyeyoung, Jung, Hosung, Lee, Daekee. 2020. STAT3-mediated MLST8 gene expression regulates cap-dependent translation in cancer cells. In Molecular oncology, 14, 1850-1867. doi:10.1002/1878-0261.12735. https://pubmed.ncbi.nlm.nih.gov/32495998/
2. Wang, Jin-Zhu, Zhu, Hong, You, Pu, Wang, Zefeng, Hui, Jingyi. . Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway. In The Journal of clinical investigation, 132, . doi:10.1172/JCI146536. https://pubmed.ncbi.nlm.nih.gov/35239512/
3. Liu, Kunpeng, Qiu, Dongbo, Liang, Xue, Qin, Yunfei, Zhang, Qi. 2021. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy. In Autophagy, 18, 860-876. doi:10.1080/15548627.2021.1961072. https://pubmed.ncbi.nlm.nih.gov/34382907/
4. Lu, Ake T, Hannon, Eilis, Levine, Morgan E, Dracheva, Stella, Horvath, Steve. 2016. Genetic variants near MLST8 and DHX57 affect the epigenetic age of the cerebellum. In Nature communications, 7, 10561. doi:10.1038/ncomms10561. https://pubmed.ncbi.nlm.nih.gov/26830004/
5. Zhang, Encheng, Chen, Siteng, Tang, Heting, Tan, Mingyue, Wang, Xiang. 2021. CDK1/FBXW7 facilitates degradation and ubiquitination of MLST8 to inhibit progression of renal cell carcinoma. In Cancer science, 113, 91-108. doi:10.1111/cas.15188. https://pubmed.ncbi.nlm.nih.gov/34741373/
6. Lu, Xiaoling, Liu, Meitong, Liao, Yuxiao, Xiong, Qiantao, Chen, Bifeng. 2021. Meta-analysis of the association between mTORC1-related genes polymorphisms and cancer risk. In Pathology, research and practice, 229, 153696. doi:10.1016/j.prp.2021.153696. https://pubmed.ncbi.nlm.nih.gov/34839094/
智鼠故事 
